Last week, the drug company AstraZeneca halted its SARS-CoV-2 vaccine trial. What happened?
As a physician-scientist, Matlock Jeffries will maintain a lab focused on osteoarthritis and will see patients in the foundation’s Rheumatology Center of Excellence.
OMRF is recruiting those who have or who think they may have Sjögren’s syndrome to participate in new research studies and a clinical trial.
Desperate times call for desperate measures.
The prospect that hydroxychloroquine might be effective for treating the coronavirus has raised hopes, but it’s also created a potential crisis.
OMRF VP of Clinical Affairs Judith James received a pair of distinguished honors at the American College of Rheumatology’s annual meeting.